Urinary JCV-DNA Testing during Natalizumab Treatment May Increase Accuracy of PML Risk Stratification
| Image |  |
|---|---|
| Description | scientific article published on 16 May 2012 |
| Author/s | |
| Publication date | May 16, 2012 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |